메뉴 건너뛰기




Volumn 20, Issue SUPPL. 4, 2005, Pages

Antipsychotics and the risk of diabetes: A general data review

Author keywords

Antipsychotics; Data review; Diabetes

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; GLUCOSE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

EID: 31944435769     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(05)80190-7     Document Type: Conference Paper
Times cited : (25)

References (37)
  • 2
    • 0033649532 scopus 로고    scopus 로고
    • American Diabetes Association: Clinical practice recommendations
    • American Diabetes Association: clinical practice recommendations Diabetes Care 23 Suppl 1 2000 S1 S116
    • (2000) Diabetes Care , vol.23 , Issue.1 SUPPL.
  • 3
    • 0348079729 scopus 로고    scopus 로고
    • American Diabetes Association: Clinical practice recommendations
    • American Diabetes Association: clinical practice recommendations Diabetes Care 25 Suppl 1 2002 S1 S147
    • (2002) Diabetes Care , vol.25 , Issue.1 SUPPL.
  • 4
    • 0030065502 scopus 로고    scopus 로고
    • Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
    • Beasley C.M. Jr, Tollefson G., Tran P., Satterlee W., Sanger T., and Hamilton S. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacology 14 2 1996 111 123
    • (1996) Neuropsychopharmacology , vol.14 , Issue.2 , pp. 111-123
    • Beasley Jr., C.M.1    Tollefson, G.2    Tran, P.3    Satterlee, W.4    Sanger, T.5    Hamilton, S.6
  • 6
    • 0037297466 scopus 로고    scopus 로고
    • A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States
    • Buse J.B., Cavazzoni P., Hornbuckle K., Hutchins D., Breier A., and Jovanovic L. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States J Clin Epidemiol 56 2003 164 170
    • (2003) J Clin Epidemiol , vol.56 , pp. 164-170
    • Buse, J.B.1    Cavazzoni, P.2    Hornbuckle, K.3    Hutchins, D.4    Breier, A.5    Jovanovic, L.6
  • 7
    • 0036939589 scopus 로고    scopus 로고
    • The risk of diabetes during olanzapine use: A retrospective database analysis
    • Caro J.J., Ward A., Levinton C., and Robinson K. The risk of diabetes during olanzapine use: a retrospective database analysis J Clin Psychiatry 63 2002 1135 1139
    • (2002) J Clin Psychiatry , vol.63 , pp. 1135-1139
    • Caro, J.J.1    Ward, A.2    Levinton, C.3    Robinson, K.4
  • 9
    • 1842684115 scopus 로고    scopus 로고
    • Retrospective analysis of risk factors in patients with treatment emergent diabetes during clinical trial of antipsychotic medications
    • Corrigendum Br J Psychiatry Suppl. 2005 May; 186:449 Cavazzoni P., Mukhopadhyay N., Carlson C., Breier A., and Buse J. Retrospective analysis of risk factors in patients with treatment emergent diabetes during clinical trial of antipsychotic medications British Journal of Psychiatry 184 Suppl 47 2004 s94 s9401
    • (2004) British Journal of Psychiatry , vol.184 , Issue.47 SUPPL.
    • Cavazzoni, P.1    Mukhopadhyay, N.2    Carlson, C.3    Breier, A.4    Buse, J.5
  • 10
    • 41549113106 scopus 로고    scopus 로고
    • Management of type 2 diabetic patients in France: Any difference among physician? the Observational Epidemiologic SIMPA Study
    • Charbonnel B., Baigts F., Dumenil V., Paillasson S., and Baleydiet A. Management of type 2 diabetic patients in France: any difference among physician? The Observational Epidemiologic SIMPA Study Diabetologia 47 Suppl 1 2004 A121
    • (2004) Diabetologia , vol.47 , Issue.1 SUPPL. , pp. 121
    • Charbonnel, B.1    Baigts, F.2    Dumenil, V.3    Paillasson, S.4    Baleydiet, A.5
  • 12
    • 0036774640 scopus 로고    scopus 로고
    • Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: Findings from a large health plandatabase
    • Gianfrancesco F.D., Grogg A.L., Mahmoud R.A., Wang R.H., and Nasrallah H.A. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plandatabase J Clin Psychiatry 63 2002 920 930
    • (2002) J Clin Psychiatry , vol.63 , pp. 920-930
    • Gianfrancesco, F.D.1    Grogg, A.L.2    Mahmoud, R.A.3    Wang, R.H.4    Nasrallah, H.A.5
  • 13
    • 0042133428 scopus 로고    scopus 로고
    • Antipsychoticinduced type 2 diabetes: Evidence from a large health plan database
    • Gianfrancesco F., White R., Wang R.H., and Nasrallah H.A. Antipsychoticinduced type 2 diabetes: evidence from a large health plan database J Clin Psychopharmacol 23 2003 328 335
    • (2003) J Clin Psychopharmacol , vol.23 , pp. 328-335
    • Gianfrancesco, F.1    White, R.2    Wang, R.H.3    Nasrallah, H.A.4
  • 15
    • 0036001466 scopus 로고    scopus 로고
    • Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of5 published cases
    • Jin H., Meyer J.M., and Jeste D.V. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of5 published cases Am Clin Psychiatry 14 2002 59 64
    • (2002) Am Clin Psychiatry , vol.14 , pp. 59-64
    • Jin, H.1    Meyer, J.M.2    Jeste, D.V.3
  • 16
    • 0036290741 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus in children and youth: A new epidemic
    • Kaufman F.R. Type 2 diabetes mellitus in children and youth: a new epidemic J Pediatr Endocrinol Metab 15 Suppl 2 2002 737 744
    • (2002) J Pediatr Endocrinol Metab , vol.15 , Issue.2 SUPPL. , pp. 737-744
    • Kaufman, F.R.1
  • 18
    • 0035990397 scopus 로고    scopus 로고
    • Olanzpine-associated diabetes mellitus
    • Koller E., and Doraiswamy P.M. Olanzpine-associated diabetes mellitus Pharmacotherapy 22 2002 841 852
    • (2002) Pharmacotherapy , vol.22 , pp. 841-852
    • Koller, E.1    Doraiswamy, P.M.2
  • 20
    • 0036738661 scopus 로고    scopus 로고
    • Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database
    • Kornegay C.J., Vasilakis-Scaramozza C., and Jick H. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database J Clin Psychiatry 63 2002 758 762
    • (2002) J Clin Psychiatry , vol.63 , pp. 758-762
    • Kornegay, C.J.1    Vasilakis-Scaramozza, C.2    Jick, H.3
  • 21
    • 0037014941 scopus 로고    scopus 로고
    • Assessment of independent effect of olanzapine and risperidone on risk of diabetes: Population based nested casecontrol study
    • Koro C.E., Fedder D.O., L'Italien G.J., Weiss S.S., Magder L.S., and Kreyenbuhl J. Assessment of independent effect of olanzapine and risperidone on risk of diabetes: population based nested casecontrol study BMJ 325 2002 243 247
    • (2002) BMJ , vol.325 , pp. 243-247
    • Koro, C.E.1    Fedder, D.O.2    L'Italien, G.J.3    Weiss, S.S.4    Magder, L.S.5    Kreyenbuhl, J.6
  • 22
    • 1842718018 scopus 로고    scopus 로고
    • Use of atypical antipsychotics and the incidence of diabetes: Evidence from a claims database
    • Lage M.J., and Kemner J.E. Use of atypical antipsychotics and the incidence of diabetes: evidence from a claims database Schizophrenia Research 53 2002 166
    • (2002) Schizophrenia Research , vol.53 , pp. 166
    • Lage, M.J.1    Kemner, J.E.2
  • 23
    • 0037315939 scopus 로고    scopus 로고
    • Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics
    • Lindenmayer J.-P., Czobor P., Volavka J., Citrome L., Sheitman B., and McEvoy J.P. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics Am J Psychiatry 160 2003 290 296
    • (2003) Am J Psychiatry , vol.160 , pp. 290-296
    • Lindenmayer, J.-P.1    Czobor, P.2    Volavka, J.3    Citrome, L.4    Sheitman, B.5    McEvoy, J.P.6
  • 26
    • 0036020018 scopus 로고    scopus 로고
    • Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent ofpsychotropic drug use
    • Regenold W.T., Thapar R.K., Marano C., Gavirneni S., and Kondapavuluru P.V. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent ofpsychotropic drug use J Affect Disord 70 2002 19 26
    • (2002) J Affect Disord , vol.70 , pp. 19-26
    • Regenold, W.T.1    Thapar, R.K.2    Marano, C.3    Gavirneni, S.4    Kondapavuluru, P.V.5
  • 28
    • 0037036159 scopus 로고    scopus 로고
    • Physical consequences of schizophrenia and its treatment: The metabolic syndrome
    • Ryan M.C.M., and Thakore J.H. Physical consequences of schizophrenia and its treatment: the metabolic syndrome Life Sci 71 2002 239 257
    • (2002) Life Sci , vol.71 , pp. 239-257
    • Ryan, M.C.M.1    Thakore, J.H.2
  • 29
    • 0036213607 scopus 로고    scopus 로고
    • Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia
    • Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., and Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia Am J Psychiatry 159 2002 561 566
    • (2002) Am J Psychiatry , vol.159 , pp. 561-566
    • Sernyak, M.J.1    Leslie, D.L.2    Alarcon, R.D.3    Losonczy, M.F.4    Rosenheck, R.5
  • 30
    • 31944451972 scopus 로고    scopus 로고
    • The relationship between antipsychotics and the development of diabetes in a VA population
    • Shermock K.M., Fuller M.A., Secic M., and Grogg A. The relationship between antipsychotics and the development of diabetes in a VA population Int J Neuropsychopharmacol 5 Suppl 1 2002 S168
    • (2002) Int J Neuropsychopharmacol , vol.5 , Issue.1 SUPPL. , pp. 168
    • Shermock, K.M.1    Fuller, M.A.2    Secic, M.3    Grogg, A.4
  • 31
    • 24244448735 scopus 로고    scopus 로고
    • A prospective cross-sectional of glucose and lipid metabolism with atypical and conventional antipsychotics
    • Smith R.C., Lindenmayer J.P., Khan M., Khandot A., and Bodala P. A prospective cross-sectional of glucose and lipid metabolism with atypical and conventional antipsychotics Biological Psychiatry 51 2002 S42
    • (2002) Biological Psychiatry , vol.51 , pp. 42
    • Smith, R.C.1    Lindenmayer, J.P.2    Khan, M.3    Khandot, A.4    Bodala, P.5
  • 32
    • 0026530811 scopus 로고
    • Adverse drug events and the freedom of information act: An apple in Eden
    • Stang P.E., and Fox J.L. Adverse drug events and the freedom of information act: an apple in Eden Ann Pharmacother 26 1992 238 243
    • (1992) Ann Pharmacother , vol.26 , pp. 238-243
    • Stang, P.E.1    Fox, J.L.2
  • 33
    • 0030993030 scopus 로고    scopus 로고
    • Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an internationalcollaborative trial
    • Tollefson G.D., Beasley C.M. Jr, Tran P.V., Street J.S., Krueger J.A., and Tamura R.N. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an internationalcollaborative trial Am J Psychiatry 154 4 1997 457 465
    • (1997) Am J Psychiatry , vol.154 , Issue.4 , pp. 457-465
    • Tollefson, G.D.1    Beasley Jr., C.M.2    Tran, P.V.3    Street, J.S.4    Krueger, J.A.5    Tamura, R.N.6
  • 34
    • 0032842391 scopus 로고    scopus 로고
    • Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. the CollaborativeCrossover Study Group
    • Tollefson G.D., Dellva M.A., Mattler C.A., Kane J.M., Wirshing D.A., and Kinon B.J. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The CollaborativeCrossover Study Group J Clin Psychopharmacol 19 5 1999 435 443
    • (1999) J Clin Psychopharmacol , vol.19 , Issue.5 , pp. 435-443
    • Tollefson, G.D.1    Dellva, M.A.2    Mattler, C.A.3    Kane, J.M.4    Wirshing, D.A.5    Kinon, B.J.6
  • 35
    • 0035060791 scopus 로고    scopus 로고
    • Lilly Resistant Schizophrenia Study Group. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible fortreatment with clozapine
    • Tollefson G.D., Birkett M.A., Kiesler G.M., and Wood A.J. Lilly Resistant Schizophrenia Study Group. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible fortreatment with clozapine Biol Psychiatry 49 1 2001 52 63
    • (2001) Biol Psychiatry , vol.49 , Issue.1 , pp. 52-63
    • Tollefson, G.D.1    Birkett, M.A.2    Kiesler, G.M.3    Wood, A.J.4
  • 36
    • 0030770872 scopus 로고    scopus 로고
    • Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
    • Tran P.V., Hamilton S.H., Kuntz A.J., Potvin J.H., Andersen S.W., and Beasley C. Jr Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders J Clin Psychopharmacol 17 5 1997 407 418
    • (1997) J Clin Psychopharmacol , vol.17 , Issue.5 , pp. 407-418
    • Tran, P.V.1    Hamilton, S.H.2    Kuntz, A.J.3    Potvin, J.H.4    Andersen, S.W.5    Beasley Jr., C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.